Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Asenapine in Bipolar I Disorder Extension
NCT01395992Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Apr 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of asenapine in bipolar I disorder, sponsored by Forest Laboratories. Started Apr 2012; status: completed.
02
Drugs
asenapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01395992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01395992.